Company / Capital Expenditures
Bio Green Med Solution, Inc. Capital Expenditures History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$13.0K
FY2017
5-year range
$3.0K / $309.0K
FY2013-FY2017
Trend
+333.3%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +333% YoY in FY2017, a notable deviation from the 6-year average annual change of +323%.
Based on SEC 10-K filings.
$13,000 in FY2017 with a 5-year CAGR of +1.6%.
Declined from $34,000 to $13,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -65.2%
- 5-Year CAGR
- +1.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +1.6%, indicating consistent growth.
- In FY2017, capital expenditures increased 333.3% year-over-year.
- Peak capital expenditures was recorded in FY2014.
- Lowest capital expenditures in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -47.65 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2017 | $13.0K | +333.3% |
| FY2016 | $3.0K | -91.2% |
| FY2015 | $34.0K | -89.0% |
| FY2014 | $309.0K | +48.6% |
| FY2013 | $208.0K | +1633.3% |
| FY2012 | $12.0K | +100.0% |
| FY2011 | $6.0K | - |
As of FY2017 · SEC Form 10-K · Last checked Jun 22, 2026